A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2011
08/25/2011	US20110207755 Use of myeloperoxidase (mpo) inhibitors or pharmaceutically acceptable salts thereof to treat multiple sysyem atrophy (msa) 938
08/25/2011	US20110207754 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
08/25/2011	US20110207753 Methods for treating pain
08/25/2011	US20110207752 P70 s6 kinase inhibitor and egfr inhibitor combination therapy
08/25/2011	US20110207751 Heterocyclic compounds and uses as anticancer agents
08/25/2011	US20110207750 Benzimidazole and aza-benzimidazole carboxamides
08/25/2011	US20110207749 Glycine Chroman-6-Sulfonamides for Use as Inhibitors of Diacylglycerol Lipase
08/25/2011	US20110207748 Tri-Aryl/Heteroaromatic Cannabinoids and Use Thereof
08/25/2011	US20110207747 2,5-Disubstituted Phenyl Carboxamide Orexin Receptor Antagonists
08/25/2011	US20110207746 New compounds i
08/25/2011	US20110207745 Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith
08/25/2011	US20110207744 Method for treating cognitive deficits
08/25/2011	US20110207743 Pyrazolylaminopyridines as inhibitors of fak
08/25/2011	US20110207742 Method for reduction, stabilization and prevention of rupture of lipid rich plaque
08/25/2011	US20110207741 Activation of the Renin-Angiotensin System (RAS) and Sudden Cardiac Death
08/25/2011	US20110207740 Pharmaceutical compositions
08/25/2011	US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011	US20110207738 Annelated pyrrolidin sulfonamides with oxadiazolone headgroup, processes for their preparation and their use as pharmaceuticals
08/25/2011	US20110207737 Substituted bicyclic amines for the treatment of diabetes
08/25/2011	US20110207736 Compounds that modulate egfr activity and methods for treating or preventing conditions therewith
08/25/2011	US20110207735 Cyanopyrimidinones
08/25/2011	US20110207734 Azine Derivatives and Methods of Use Thereof
08/25/2011	US20110207733 Pyrimidine derivatives for treatment of alzheimer's disease
08/25/2011	US20110207732 Azaindole derivatives
08/25/2011	US20110207731 Substituted 4-(indazolyl)-1,4-dihydropyridines and methods of use thereof
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110207729 Bicyclic acylguanidine derivative
08/25/2011	US20110207728 Compounds for treating respiratory syncytial virus infections
08/25/2011	US20110207727 Thio-subsituted Anthra [1, 2-d] imidazole- 6, 11-dione Dervatives, Preparation Method and application thereof
08/25/2011	US20110207726 Inhibitors of Human Cathepsin L, Cathepsin B, and Cathepsin S
08/25/2011	US20110207725 CHIRAL FUSED [1,2]IMIDAZO[4,5-c] RING COMPOUNDS
08/25/2011	US20110207724 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anit-hypertensive compounds
08/25/2011	US20110207723 Novel fused aminodihydrothiazine derivative
08/25/2011	US20110207722 Treatment of anxiety disorders
08/25/2011	US20110207721 Purine derivatives as kinase inhibitors
08/25/2011	US20110207720 Quinolin-4-one and 4-oxodihyrdocinnoline derivatives as inhibitors of poly(adp-ribose) polymerase (parp)
08/25/2011	US20110207719 Novel Anthra [1, 2-d]imidazole-6,11-dione Derivatives, Preparation Method and application thereof
08/25/2011	US20110207718 Compositions and methods for treating psychiatric disorders
08/25/2011	US20110207717 2-aminopyrimidine compounds as serotonin receptor modulators
08/25/2011	US20110207716 Inhibitors of polo-like kinase
08/25/2011	US20110207715 Disubstituted Azepan Orexin Receptor Antagonists
08/25/2011	US20110207714 Serotonin receptor modulators
08/25/2011	US20110207713 PYRIDO[3,2-d]PYRIMIDINE PI3K DELTA INHIBITOR COMPOUNDS AND METHODS OF USE
08/25/2011	US20110207712 Phosphatidylinositol 3-Kinase Inhibitors And Methods Of Their Use
08/25/2011	US20110207711 Therapeutic Compounds
08/25/2011	US20110207710 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase a2 (spla2) inhibitors and spla2 inhibitor combination therapies
08/25/2011	US20110207709 Modulators of serotonin receptor
08/25/2011	US20110207708 Androgen Treatment in Females
08/25/2011	US20110207706 Methods for Treating Spinal Muscular Atrophy Using Tetracycline Compounds
08/25/2011	US20110207705 Oviedomycin derivatives, method for obtaining same and use thereof
08/25/2011	US20110207704 Novel Oxadiazole Compounds
08/25/2011	US20110207703 Oxidized lipid compounds and uses thereof
08/25/2011	US20110207702 Boron-containing small molecules as anti-protozoal agents
08/25/2011	US20110207701 Boron-containing small molecules as antiprotozoal agents
08/25/2011	US20110207700 Tricyclic compound and use thereof
08/25/2011	US20110207699 Anti-Viral Compounds
08/25/2011	US20110207698 Heteroaryl-substituted dicyanopyridines and their use
08/25/2011	US20110207697 Xanthohumol compositions and methods for treating skin diseases or disorders
08/25/2011	US20110207696 Compositions for treating rosacea
08/25/2011	US20110207695 Agent for applying to mucosa and method for the production thereof
08/25/2011	US20110207694 Mammalian hypothalamic nutrient modulation of glucose metabolism
08/25/2011	US20110207693 Oral B12 Therapy
08/25/2011	US20110207692 Combinations of sapacitabine or cndac with dna methyltransferase inhibitors such as decitabine and procaine
08/25/2011	US20110207691 Cobalamin compositions for the treatment of cancer
08/25/2011	US20110207690 Compositions and methods for treating viral infections
08/25/2011	US20110207689 The treatment of hearing loss
08/25/2011	US20110207688 Heterocyclic antiviral compounds
08/25/2011	US20110207687 Fulvic acid and antibiotic combination
08/25/2011	US20110207686 Polysaccharide-and polypeptide-based block copolymers, vesicles constituted by these copolymers and use thereof
08/25/2011	US20110207685 Oral Formulations of Chemotherapeutic Agents
08/25/2011	US20110207684 New low side effect pharmaceutical composition containing isoniazid
08/25/2011	US20110207683 Natural colorant and methods thereof
08/25/2011	US20110207682 Pharmaceutical composition useful for the treatment of peptic ulcer diseases
08/25/2011	US20110207681 Use of glucosylglycerol
08/25/2011	US20110207680 Administration of Glufosfamide For The Treatment of Cancer
08/25/2011	US20110207679 Methods of treatment using il-16 antagonist peptides
08/25/2011	US20110207672 Methods of treatment using a prodrug of an excitatory amino acid
08/25/2011	US20110207665 Method of regulating proliferation and differentiation of keratinocyes
08/25/2011	US20110207661 Benzylbenzene derivatives and methods of use
08/25/2011	US20110207659 Oligosaccharide compositions and use thereof in the treatment of infection
08/25/2011	US20110207656 MUC1, CASPASE-8, and DED-CONTAINING PROTEINS
08/25/2011	US20110207604 Isolated bacterial strain of the genus burkholderia and pesticidal metabolites therefrom
08/25/2011	US20110207224 In vivo production of small interfering rnas that mediate gene silencing
08/25/2011	US20110206794 Fruit extracts
08/25/2011	US20110206783 P2x3, receptor antagonists for treatment of pain
08/25/2011	US20110206782 Piperidine modulators of dopamine receptor
08/25/2011	US20110206781 Method to modulate hematopoietic stem cell growth
08/25/2011	US20110206780 Morphinan modulators of nmda receptors, sigma1 receptors, sigma2 receptors, and/or a3b4 nicotinic receptors
08/25/2011	US20110206775 Preparation of inert pharmaceutical excipients for stabilizing unstable pharmaceutical ingredients
08/25/2011	US20110206773 Sustained delivery of drugs from biodegradable polymeric microparticles
08/25/2011	US20110206770 Atovaquone with a particle size diameter range (d90) of greater than 3 microns to about 10 microns
08/25/2011	US20110206769 Oral antidepressant formulation with reduced excipient load
08/25/2011	US20110206767 Pharmaceutical composition
08/25/2011	US20110206766 Dpp-iv inhibitor combined with a further antidiabetic agent, tablets comprising such formulations, their use and process for their preparation
08/25/2011	US20110206764 Formulations for enhanced bioavailability of orally administered polar agents
08/25/2011	US20110206762 Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
08/25/2011	US20110206761 Stable dosage forms of antihypertensive agents
08/25/2011	US20110206756 Dithiocarbamate metal chelates and methods of making and using thereof
08/25/2011	US20110206755 Methods and products for manipulating uncoupling protein expression
08/25/2011	US20110206754 Implant device

1 ... 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 ... 7860